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Abstract
Leukocyte-endothelial cell interactions and leukocyte activation are important factors for vascular diseases including
nephropathy, retinopathy and angiopathy. In addition, endothelial cell dysfunction is reported in vascular disease condition.
Endothelial dysfunction is characterized by increased superoxide (O2
N2) production from endothelium and reduction in NO
bioavailability. Experimental studies have suggested a possible role for leukocyte-endothelial cell interaction in the vessel
NO and peroxynitrite levels and their role in vascular disorders in the arterial side of microcirculation. However, anti-
adhesion therapies for preventing leukocyte-endothelial cell interaction related vascular disorders showed limited success.
The endothelial dysfunction related changes in vessel NO and peroxynitrite levels, leukocyte-endothelial cell interaction and
leukocyte activation are not completely understood in vascular disorders. The objective of this study was to investigate the
role of endothelial dysfunction extent, leukocyte-endothelial interaction, leukocyte activation and superoxide dismutase
therapy on the transport and interactions of NO, O2
N2 and peroxynitrite in the microcirculation. We developed a
biotransport model of NO, O2
N2 and peroxynitrite in the arteriolar microcirculation and incorporated leukocytes-endothelial
cell interactions. The concentration profiles of NO, O2
N2 and peroxynitrite within blood vessel and leukocytes are presented
at multiple levels of endothelial oxidative stress with leukocyte activation and increased superoxide dismutase accounted
for in certain cases. The results showed that the maximum concentrations of NO decreased ,0.6 fold, O2
N2 increased ,27
fold and peroxynitrite increased ,30 fold in the endothelial and smooth muscle region in severe oxidative stress condition
as compared to that of normal physiologic conditions. The results show that the onset of endothelial oxidative stress can
cause an increase in O2
N2 and peroxynitrite concentration in the lumen. The increased O2
N2 and peroxynitrite can cause
leukocytes priming through peroxynitrite and leukocytes activation through secondary stimuli of O2
N2 in bloodstream
without endothelial interaction. This finding supports that leukocyte rolling/adhesion and activation are independent
events.
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Introduction
Leukocyte-endothelial cell interactions and leukocyte activation
are important factors for onset and progression of vascular diseases
including nephropathy, retinopathy, cardiomyopathy, neuropathy
and angiopathy [1,2,3,4]. It is reported that the presence of
leukocytes along the endothelium and the activation of leukocytes
results in complications such as tissue edema and multiple organ
failure [5,6,7]. Studies have shown that leukocyte-endothelial cell
interactions are necessary for onset of microvascular dysfunction
and tissue injury [8,9,10]. However, anti-adhesion therapies used
to prevent vascular complications arising from leukocyte-endothe-
lial cell interactions have not been very successful [7].
Vascular disease conditions increase oxidative stress in endo-
thelial cells, resulting in endothelial dysfunction [11]. As shown in
Figure 1, endothelial dysfunction is characterized by increased
superoxide (O2
N2) production from endothelium and a reduction
in NO bioavailability [11,12]. There are many hypotheses for the
reduction in NO bioavailability. The most important characteristic
is a rapid reaction between NO and O2
N2 to form peroxynitrite,
which may reduce the NO availability even when NO production
is increased under oxidative stress conditions [13,14]. The
increased oxidative stress increases cytokines, inflammatory agents
and adhesion molecules expression on the endothelial cell surface
and their ligands expression on the surface of the leukocytes
[15,16] resulting in recruitment of leukocytes to the endothelium
[2,15,16,17].
The process of leukocyte activation and transmigration is
complex. Before activation of leukocyte, the leukocytes are
converted to semi-activated state by a process of priming with
the aid of priming agents [7,18]. Priming agents include
peroxynitrite [19], cytokines (TNF-a) and pro-inflammatory
agents PAF (platelet-activating factor) and leukotriene B4 [6,7,8].
Secondary stimuli such as reactive oxygen species (ROS) are
required to activate primed leukocytes [6,20]. Upon activation,
leukocytes release nitric oxide (NO), ROS and cytokines [7,18,21].
In literature, there is no clear evidence that leukocyte recruitment,
priming and activation are sequential. There are multiple sources
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e38912of ROS in blood vessel. ROS from endothelium may act as a
secondary stimuli and activate primed leukocytes.
It has been reported that excess NO and O2
N2 production in the
vasculature from leukocyte-endothelial cell interactions causes
significant increase in peroxynitrite formation as indicated by
increased tyrosine nitration [22]. Therefore, together with NO
and O2
N2, the formation of peroxynitrite are important contrib-
utors for the vascular disorders [4,18]. The release of NO and
O2
N2 by leukocytes increases O2
N2 and peroxynitrite concentration
within different regions of the microvasculature [23,24] and
increases endothelial cell Ca
2+ levels [6,25]. The increase in
endothelial cell Ca
2+ levels initiates signaling pathways for
increasing vascular permeability [25]. Increased vascular perme-
ability causes extravasation of leukocytes into the tissue region
leading to tissue injury and complications such as tissue edema
[7,26].
Many studies have investigated the effects of leukocyte-
endothelial cell interactions on microvascular functions including
permeability [5,8,25], vascular tone [27],vessel hemodynamics
[28,29], tissue injury [10,30] and organ dysfunction [27]. Majority
of these studies focused on venular microcirculation. However,
there is increasing evidence of leukocyte-endothelial cells interac-
tion in arteriolar microcirculation [5,15,16,17,26,29]. The expres-
sion of adhesion molecules is upregulated in arteriolar endothe-
lium under inflammatory conditions [5,15,16,29] similar to
venules. The leukocyte-endothelial cell interactions between
venules and arterioles varies in terms of the adhesion molecules
expression levels and their contribution to leukocyte-endothelial
interaction and number of leukocytes adhering along the
endothelium [15,17]. Besides the changes in vessel parameters
and surrounding cells in arterioles and venules, RBCs in venules
are relatively unbound to O2 whereas RBC are bound to oxygen
in arterioles [31]. Though a significant number of leukocytes can
adhere to the venular endothelium and eventually transmigrate
[17], a small number of leukocytes is reported to interact with the
arteriolar endothelium [15,17].
Despite the minimal interactions of leukocyte-endothelial cell in
arterioles, the vascular disorders in arteriolar microcirculation are
similar to those observed in venules [5,15,17]. Okamoto et al. [32]
reported an increased inflammation in the adventitial region of
coronary arterioles that is attributed to increased expression of
adhesion molecules in the endothelium, leukocyte infiltration into
the adventitia and release of ROS by the leukocytes. Murohara et
al. [33] reported that H2O2 (a ROS) treated arteries showed
significant increase in vasoconstriction and adhesion of leukocytes
to the endothelium. In addition, Suamgin et al. [5] reported an
increase in vessel permeability on transition from control to
inflammatory conditions for arterioles and venules. Studies have
also shown that increased leukocyte-endothelial cell interactions
can lead to increased O2
N2 production from the leukocytes [8] and
the endothelium [9]. The increase in O2
N2 production from the
leukocytes and endothelium lowers the bioavailability of NO by
converting it to peroxynitrite [18,22]. These studies suggests the
possible role that leukocyte-endothelial cell interaction in the vessel
NO and peroxynitrite levels can also contribute to vascular
disorders in the arterial side of microcirculation. Thus, it is
important to understand the transport and interactions of NO,
Figure 1. Schematic representation of the role of endothelial dysfunction on leukocyte related events through interactions
between free radical species (NO, ROS and peroxynitrite). The free radical species are represented by the orange ovals, the leukocyte related
events and endothelial dysfunction are represented by the yellow compartments and the chemical species expressed as a result of the interactions of
free radicals (cytokines, adhesion molecules and inflammatory agents) are represented by the light green compartments. Endothelial dysfunction
leads to increased ROS production from endothelium and a possible reduction in NO availability (indicated by the dashed lines). The ROS and NO
combine to form peroynitrite (Per). ROS and peroxynitrite increase expression of adhesion molecules and cytokines leading to leukocyte recruitment
and priming. Peroxynitrite and ROS can also prime and activate primed leukocytes, respectively. The dashed lines connecting the leukocyte related
events shows the uncertaintly associated with their sequential nature.
doi:10.1371/journal.pone.0038912.g001
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N2 and peroxynitrite in the microcirculation during leukocyte-
endothelial cell interaction.
In this study, we examined the biochemical aspects of oxidative
stress distribution during the presence of leukocytes (both inactive
and activated states) along the endothelium to understand the
effects of leukocyte-endothelium interaction on NO, O2
N2 and
peroxynitrite profiles. A computational model simulating the
biotransport of these species in an arteriolar vessel with leukocytes
positioned along the luminal surface of the endothelium was
developed in both inactive and active state under several
endothelial oxidative stress states. Additionally, the effect of the
anti-oxidant superoxide dismutase on the arteriolar NO, O2
N2 and
peroxynitrite concentration distribution was also analyzed.
Materials and Methods
A computational model representing the transport of NO, O2
N2
and peroxynitrite in an arteriole of 50 mm diameter and 500 mm
length was developed in this study. Three elliptical leukocytes were
positioned along the luminal side of the endothelium. We were
interested in understanding the effects of the presence of these
leukocytes on the local oxidative and nitrosative stress distribution
in the vessel. The model simulations predicted the NO, O2
N2 and
peroxynitrite concentration at different regions of the arteriole and
within these leukocytes.
Model Geometry
A cylindrical geometry with concentric cylinders was used to
represent the arteriole and its associated regions as shown in
Figure 2. These regions include the luminal RBC (red blood cell)
rich region (CR), RBC free region next to the vessel wall (CF),
endothelium (E), interstitial space (IS) between the endothelium
and smooth muscle cells, smooth muscle layer (SM), non-perfused
parenchymal tissue (NPT) and perfused parenchymal tissue (PT)
region. The CR region in the lumen of the arteriole was
considered to have a homogenous solution of RBC’s [34]. The
thickness of these different regions is shown in Table 1. Three
leukocytes were positioned on the luminal side of the endothelium
for all the cases simulated and were named as L1, L2 and L3,
respectively. Details about the leukocyte geometry and positioning
of the leukocytes are described in the ‘‘Model Parameters’’
subsection.
Model Assumptions
The following were the assumption of the mathematical model:
1) The convective transport of the species (NO, O2
N2 and
peroxynitrite) was assumed in the lumen (CR and CF
regions) due to blood flow.
2) The geometric parameters including thickness of the CR
and CF regions were based on systemic hematocrit and
vessel diameter [35].
3) The NO production rate from the endothelium was
proportional to the shear stress exerted on the vessel wall
due to blood flow [36]. The shear stress on the vessel wall
was calculated from apparent viscosity of blood (3 cPs),
vessel diameter and physiological blood velocity (0.5 cm.s
21)
using Newton’s law of viscosity [36]. The apparent blood
viscosity was obtained from literature and is a function of
systemic hematocrit [37].
4) The basal case O2
N2 production in the endothelium and
capillary was assumed at 5% of their respective NO
production. In basal case, leukocytes in inactivated state
were modeled. We changed the NO production rate from
the leukocytes and the O2
N2 production rate in the
endothelium, capillary and leukocytes depending on simu-
lated-cases. These changes are described later in this section.
5) The boundaries separating the different regions of the
arteriole geometry and the outer surface of the perfused
parenchymal tissue (PT) region were considered rigid.
6) The simulations were performed at steady state.
7) We assumed laminar flow in the lumen. The presence of
leukocytes may affect the blood velocity profile. However, at
physiological velocity, the convective transport of the
modeled species can be neglected [38,39].
8) The arteriole geometry was considered to be axially
symmetric and hence the computational domain involved
only half of the complete vessel geometry starting from the
central axis of the vessel to the outer surface of PT region.
This assumption will affect the profile only when there is
another leukocyte in the vicinity.
9) We used three leukocytes for our simulations based on the
experimental observations for leukocyte rolling flux and
rolling velocity for TNF-a treated arterioles of ICAM-1 KO
mice and wild type (WT) mice [15]. Their reported values
were 7 leukocytes/40 s and 32.2 mm.s
21 for ICAM-1 KO
mice and 13 leukocytes/40 s and 53.5 mm.s
21 for WT mice.
These two values results in 3.2 and 3.03 leukocytes per
500 mm vessel length. The calculations were performed
based on the time taken by one leukocyte to traverse the
length of the arteriole and the leukocyte rolling flux in that
time period. It was also reported that in inflammatory
conditions about 0.64 leukocytes/100 mm were adhered to
arteriolar endothelium [15], which translated to 3 adhered
leukocytes for the vessel length used in this study (500 mm).
Governing Equations
The transport of NO, O2
N2 and peroxynitrite across different
regions of the arteriole and within the leukocytes occurs due to
both diffusion and convection. Additionally, these three species are
also produced and consumed in different regions of the arteriole.
Thus, the governing equation for their transport is a combination
of the diffusion, convection, production and reaction kinetic terms.
The transport of the three different chemical species (NO, O2
N2
and peroxynitrite) were represented by three separate equations.
The equations for mass transfer of NO, O2
N2 and peroxynitrite
across all the regions of the arteriole and the leukocyte were in the
following form:
1
r
Di
L
Lr
r
LCi
Lr
  
{
X
Ri,jz
X
Pi,j~vz
LCi
Lz
ð1Þ
Where the suffix i represents the chemical species (NO, O2
N2 and
peroxynitrite) and j the respective regions (i.e. CR, CF, E, IS, SM,
NPT, PT, L1, L2 and L3). Di (cm
2.s
21) is the diffusivity of species
i, Ci (nM) is the concentration of species i, Ri,j (M.s
21) represents
the reaction rate of species i in the region j and Pi,j represents the
production rate of species i in the region j (M.s
21). vz (m.s
21) is the
axial component of blood flow velocity and is a function of radial
distance r [40]. The blood flow was within the laminar flow range
based on apparent Reynolds number calculations using a value of
3 cPs for apparent blood viscosity [36]. Therefore, a parabolic
velocity distribution of luminal blood flow was considered in this
study. The velocity distribution was represented as a function of
radial distance (r) in the following form [40]:
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PLoS ONE | www.plosone.org 3 June 2012 | Volume 7 | Issue 6 | e38912Figure 2. Geometrical description of the problem. Panel A shows the schematic of the arteriolar geometry. The geometry consists of
concentric cylinders representing the different regions of the arteriole. The different regions fall under the category of either luminal or abluminal
region. The luminal and abluminal regions are separated by the endothelial region (E). The luminal region consists of the RBC rich core (CR) and RBC
free plasma region (CF). The abluminal region consists of the interstitial region (IS), smooth muscle region (SM), non-perfused (NPT) and capillary
perfused (PT) parenchymal regions. L1, L2 and L3 represent the leukocytes interacting with the endothelium. Pin and Pout represent the inlet and
outlet of the arteriolar/vessel segment, respectively. P1 and P2 represent the locations where the radial concentration profiles of NO, O2
N2 and
peroxynitrite were obtained and are located at distances of 230 and 345 mm, respectively from Pin. Panel B shows the schematic of finite element
mesh grid with relative accuracy set to 0.001.
doi:10.1371/journal.pone.0038912.g002
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Where R (mm) is the radius of the arteriole (25 mm) and vzmax is
the velocity of blood at the center of the arteriole (r=0), which is
also the maximum value of velocity.
Boundary Conditions
The zero flux boundary condition was applied to the center of
the arteriole (r=0) and at the outer surface of the perfused
parenchymal tissue (PT) region. The boundary conditions of
continuity of NO, O2
N2 and peroxynitrite were applied at all the
interfaces with the exception of the interface between (a) the
endothelium and the luminal cell free (CF) region and (b) the
interstitial space (IS) and endothelium (E). At these interfaces, the
boundary conditions involve the endothelium based NO and O2
N2
production. Mathematically, the boundary condition at the
interface between cell free (CF) and endothelium (E) region can
be represented as follows:
Di
LCi,CF
Lr
{Di
LCi,E
Lr
~Pi,E ð3Þ
The boundary condition at the interface between the interstitial
space (IS) and endothelium (E) can be mathematically represented
as:
Di
LCi,E
Lr
{Di
LCi,IS
Lr
~Pi,E ð4Þ
In equation (3) and equation (4) the term Pi,E represents NO and
Table 1. Model Parameters.
Parameter Value Units Reference
Systemic hematocrit 45 % [34,41]
Capillary hematocrit 30 % [40,41]
CRBC-Hb 20.3 mM [40,41]
Arteriole radius 25 mmT e x t
CF region thickness 4.5 mm [35,40,41]
Endothelial thickness 0.5 mm [40,41]
IS region thickness 0.5 mm [41]
SM region thickness 6 mm [40,41]
NPT region thickness 30 mm [40,41]
O2 concentration 27 mM [41]
CO2 concentration 1.1 mM [41]
SOD concentration 1, 10 mM [56], Text
PNO,E 5.3610
212 moles.cm
22.s
21 [40,43,44]
PO2
N2
,E 2.7610
213, 1.06610
212,5 . 3 610
212 moles.cm
22.s
21 [41], Text
PNO,PT 8.6610
27 M.s
21 [40], Text
PO2
N2
,PT 4.3610
28, 1.72610
27,8 . 6 610
27 M.s
21 [41], Text
PNO,L1,L2,L3 10 mM.s
21 [45]
PO2
N2
,L1,L2,L3 4.11610
25 M.s
21 [46]
DNO 3.3610
25 cm
2.s
21 [41]
DO2
N2 2.8610
25 cm
2.s
21 [41,50]
DPer 2.6610
25 cm
2.s
21 [41,50]
f (tissue) 0.640 [41]
f (lumen) 0.817 [41]
vzmax 0.5 cm.s
21 [36,40]
kNO-RBC 0.2610
5 M
21.s
21 [34,55]
kcap 1.77 s
21 [40,41]
kNO-O2 9.6610
6 M
22.s
21 [40,41]
kSM 5610
4 M
21.s
21 [41]
kPer 6.7610
9 M
21.s
21 [41,89]
ksod 1.6610
9 M
21.s
21 [41,89]
koxy 4.5 s
21 [56]
kCO2 5.6610
4 M
21.s
21 [41]
khb1 30 s
21 [56]
kNO-Per 9.1610
4 M
21.s
21 [41]
doi:10.1371/journal.pone.0038912.t001
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N2 production in the endothelium. In the case of peroxynitrite,
the continuous boundary condition was applied across all the
interfaces as it was not produced directly in any region of the
arteriole or within the leukocytes (PPer, j=0).
Cases Simulated
Our understanding of the effects of the presence of leukocytes
along the endothelium under different levels of endothelial
oxidative stress and during activation of leukocytes is lacking.
Five different cases were simulated to mimic the different levels of
endothelial oxidative stress and leukocyte activation. The cases are
as follows:
Case 1. A normal physiologic condition 2 In these simula-
tions, basal level of endothelial oxidative stress (O2
N2 production in
the endothelium and capillary was set at 5% of their respective
NO production) and leukocytes in inactivated state were modeled.
Case 2. Endothelial oxidative stress condition 2 In these
simulations, the O2
N2 production in the endothelium and capillary
was set at 20% of their respective NO production and leukocytes
were in inactivated state.
Case 3. Combination of endothelial oxidative stress and
activation of leukocytes 2 The O2
N2 production in the endothe-
lium and capillary was set at 20% of their respective NO
production and leukocytes were in activated state producing NO
and O2
N2. The next two cases are based on this case. One is a
therapeutic scenario and another is a severe oxidative stress
condition that is the exacerbation of the Case 3 in the absence of
any treatment.
Case 4. Combination of endothelial oxidative stress, activated
leukocytes and increased SOD concentration (a therapeutic
scenario) 2 SOD concentration was increased by an order of
magnitude from 1 mMt o1 0mM globally across all regions of the
arteriole geometry. Other conditions were the same as the Case 3.
Case 5. Severe oxidative stress condition 2 The O2
N2
production in the endothelium and capillary was set at 100% of
their respective NO production and leukocytes were in activated
state producing NO and O2
N2.
Sources of NO and O2
N2 Production
NO and O2
N2 production occurs at the luminal and abluminal
surfaces of the endothelium [41]. The primary endothelium based
NO source is the enzyme endothelial nitric oxide synthase (eNOS)
while the primary endothelial O2
N2 sources include NADPH
oxidase and uncoupled eNOS [41,42]. NO and O2
N2 production
also takes place in the perfused section of the parenchymal tissue
region (PT) from capillary endothelium [34,41] and in the
leukocytes upon activation [7,20,25]. Kavdia and Popel [36]
proposed the following relationship between wall shear stress and
endothelial NO release rate:
PNO,E~PNO control,E
twall
twall control
ð5Þ
PNO_control,E is the basal rate of NO release by the endothelium at
control wall shear stress (twall_control) of 24 dyne.cm
22 correspond-
ing to the physiological blood velocity of 0.5 cm.s
21 and an
apparent blood viscosity of 3 cPs in a 50 mm diameter arteriole
[36]. The control NO production rate in the endothelial region
(PNO_control,E) used in this study was 5.3610
212 moles.cm
22.s
21
based on the experimental data of Malinski et al. [43,44] in rabbit
aorta. The basal rate of capillary based NO production in PT
region is calculated from the endothelium based NO release rate
by Kavdia and co-workers [34,35] and was estimated to be
(PNO_control,PT) 8.6610
27 M.s
21.
The O2
N2 production in these two regions (E and PT) was
assumed to be a fraction of their respective NO production rates
[41] and varied as described in Cases Simulated subsection above.
The leukocyte NO and O2
N2 production rate were assumed to be
10 mM.s
21 and 41.1 mM.s
21, respectively. The leukocyte NO
production rate was calculated from the inducible NOS (iNOS)
enzyme based NO production rates from leukocytes of 3
pmoles.s
21/10
6 cells reported by Nalwaya and Deen [45] The
leukocyte O2
N2 production rate was calculated from the O2
N2
release rates of 12.33 pmoles.s
21/10
6 cells reported by Tsukimori
et al. [46]. The volume of 300 mm
3 for a single leukocyte reported
by Ting-Beall et al. [47] was used to convert both these production
rates into appropriate Molar units. The values of the NO and
O2
N2 production rates in the endothelium, perfused parenchymal
region and leukocytes for the different cases simulated (Case 1 to
Case 5) are shown in Table 2.
Chemical Reactions
NO, O2
N2 and peroxynitrite undergo chemical reactions at all
or specific regions within the arteriole geometry. The specifics of
these reactions are shown in Table 3. The rate constants
pertaining to the different chemical reactions were either directly
procured from literature or calculated (such as kcap). Amongst the
reactions shown in Table 3, the reaction involving NO and
hemoglobin (Hb) in the CR and PT regions involve the two
reactants (NO and Hb) and the RBC. The rate of consumption of
NO by Hb in the CR region is represented as the product of NO
reaction rate constant with RBC Hb (kNO-RBC), concentration of
Hb in a single RBC (CRBC-Hb), systemic hematocrit and NO
concentration. The values of these parameters and their sources
Table 2. Endothelial, capillary and leukocyte based NO and O2
N2 production rates and SOD concentration for the different cases
simulated.
Case Number Pi,E (pmoles.cm
22.s
21)P i,PT (mM.s
21) CSOD (mM) Pi,L
1 (mM.s
21)
NO O2
N2 NO O2
N2 NO O2
N2
Case 1 5.3 0.27 0.86 0.043 1 0 0
Case 2 5.3 1.06 0.86 0.172 1 0 0
Case 3 5.3 1.06 0.86 0.172 1 10.0 41.1
Case 4 5.3 1.06 0.86 0.172 10 10.0 41.1
Case 5 5.3 5.3 0.86 0.86 1 10.0 41.1
1Pi,L refers to the production rate of NO and O2
N2 from the leukocytes L1, L2 and L3.
doi:10.1371/journal.pone.0038912.t002
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between NO and RBC is represented as the product of effective
rate constant of reaction between NO and Hb in blood flowing in
capillaries perfusing in the PT region (kcap) and the concentration
of NO. kcap is obtained by multiplying the NO reaction rate
constant with RBC Hb (kNO-RBC), concentration of Hb in RBC
(CRBC-Hb), capillary hematocrit and fractional capillary volume.
The value of fractional capillary volume used was 0.0146 based on
experimental data reported for hamster retractor muscle [35,48].
The other parameters used in calculation of kcap are shown in
Table 1. Details regarding the calculation of kcap can be found in
articles by Kavdia and co-workers [35,40,41].
Model Parameters
The model parameters are reported in Table 1. The dimensions
of the elliptical leukocyte (semi-major and semi-minor axis) were
assumed to be 4.9 and 3.5 mm, respectively. The leukocyte
dimensions were based on the observations of deformation index
of 1.36 by Damiano et al. [49] and a spherical diameter of
leukocytes in resting state of 8.3 mm by Ting-Beall et al. [47].
Damiano et al. [49] observed that adhesion molecule expression
and shear stress due to blood flow contribute to change in
leukocyte morphology from circular to elliptical and expressed this
change in terms of a deformation index. The centers of these three
leukocytes were located at distances of 38, 230.8 and 461.5 mm,
respectively from the vessel inlet (Pin) and at a radial distance of
3.5 mm from the luminal surface of the endothelium as shown in
Figure 2A. The justification for other geometrical parameters is
presented in earlier studies [35,40,41]. For all the regions of the
arteriole and within the leukocytes, the diffusivity of NO, O2
N2 and
peroxynitrite were 3.3610
25, 2.8610
25 and 2.6610
25 cm
2.s
21,
respectively [41,50].
Numerical Solution
On the basis of Equation 1, a system of partial differential
equations were generated for representing the transport and
reactions involving NO, O2
N2 and peroxynitrite. These equations
with the appropriate boundary conditions were solved numerically
using the finite element software package FlexPDE 5.0 (PDE
solutions Inc., Antioch, CA, USA). This software uses adaptive
meshing that generates finer elements in regions with steep
concentration gradient and coarse meshing elsewhere within the
domain as shown in Figure 2B. This optimizes the computational
resources required for the simulations. For all the simulations used
in this study, we used a relative accuracy of 0.001.
Results
The model used in this study predicts the steady state NO, O2
N2
and peroxynitrite concentration distribution and radial profiles
under normal and oxidative stress conditions in the presence of
three leukocytes located along the luminal surface of the
endothelium. The steady state radial concentration profiles of
NO, O2
N2 and peroxynitrite were obtained at two distinct
locations along the axial direction of the arteriole as shown in
Figure 2A and B. The first location passes through one of the
leukocyte (location P1 in Figure 2A and B) present along the
endothelium (L2). The second location passes through the
midpoint between the centers of two leukocytes present along
the endothelium (location P2 in Figure 2A and B between
leukocytes L2 and L3). The first location was at a distance of
230 mm and the second at a distance of 345 mm. The NO
concentration increased radially along the arteriole starting at the
vessel center. The O2
N2 and peroxynitrite concentration increased
radially starting at the vessel center to a maximum at the
endothelium (in some cases near the endothelium as stated) and
Table 3. Description of reactions and their kinetic expressions used in the model.
Rxn # Reaction Regions Mathematical Expression Ref.
Rxn 1 NO and Hb CR -RNO,CR~kNO{RBCCRBC{HbCNO [40,41]
Rxn 2 NO and Hb PT -RNO,PT~kcapCNO [40,41]
Rxn 3 NO and O2 CF, E, IS & NPT -RNO,j~kNO{O2CNO
2CO2 [41]
Rxn 4 NO and sGC SM -RNO,j~kSMCNO
2 [40,41]
Rxn 5 NO and O2
N2 All -RNO,j~RPer,j~kPerCNOCO.{
2 [41,56]
Rxn 6 O2
N2 and SOD All {RO.{
2 ,j~ksodCO.{
2 CSOD [41,56]
Rxn 7 Peroxynitrite Dissociation All -RPer,j~koxy(1{f)CPer
f~ 1
1z10pKper{pH ~
CONOO{
CONOO{ zCONOOH
[41,56]
Rxn 8 Peroxynitrite & CO2 All -RPer,j~kCO2fCPerCCO2 [41]
Rxn 9 Peroxynitrite & Hb CR & PT -RPer,j~khb1fCPer [56]
Rxn 10 Peroxynitrite & NO All -RNO,j~{RPer,j~kNO{PerfCPerCNO [41,56]
doi:10.1371/journal.pone.0038912.t003
Table 4. Maximum endothelial concentrations of NO, O2
N2
and peroxynitrite at location P1
2 and location P2
3.C Per refers
to the peroxynitrite concentration.
Case Number CNO (nM) CO2
N- (pM) CPer (nM)
P1 P2 P1 P2 P1 P2
Case 1 262 250 431 426 2 2
Case 2 240 229 1761 1741 6 6
Case 3 226 229 5801 1741 41 6
Case 4 285 251 1064 704 8 1
Case 5 153 150 13447 9591 51 24
2The location P1 refers to a straight line passing through the leukocyte L2 at a
distance of 230 mm from the vessel inlet Pin as seen in Figure 2.
3The location P2 refers to a straight line passing the centers of leukocytes L2
and L3 at a distance of 345 mm from the vessel inlet Pin as seen in Figure 2.
doi:10.1371/journal.pone.0038912.t004
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N2 and
peroxynitrite concentrations at locations P1 and P2 for all the cases
(Case 125) are shown in Table 4. The NO, O2
N2 and
peroxynitrite concentration range in the different regions of the
arteriole is shown in Table 5.
Concentration Distribution and Profiles of NO, O2
N2 and
Peroxynitrite Under Normal Physiological Conditions
(Case 1)
Under normal physiological conditions, a small number of
leukocytes may still roll along the endothelium primarily acting as
surveillance against antigens or pathogenic foreign bodies [51].
Additionally, a small amount of O2
N2 is released from endothelial
cells under normal physiologic conditions [41,52]. In this case
(Case 1), leukocytes were considered to be inactivated as they are
neither primed nor activated under normal physiologic conditions
[7,20,53,54].
The NO, O2
N2 and peroxynitrite concentrations are shown in
Figure 3A, C and E, respectively for the entire vessel and in
Figure 3B, D and F, respectively for a segment of the vessel
between 200 and 300 mm encompassing the luminal, endothelial
(E), smooth muscle (SM) and non-perfused parenchymal tissue
(NPT) region. The concentration range of NO, O2
N2 and
peroxynitrite within the leukocytes were 882248 nM,
0.22200 pM, and 122 nM, respectively. The concentration
range of NO, O2
N2 and peroxynitrite at other regions of the
arteriole are shown in Table 5. The radial concentration profiles
for NO, O2
N2 and peroxynitrite at location P1 and P2 are shown in
Figure 4 A and B, respectively and their maximum values at the
endothelium are shown in Table 4.
Concentration Distribution and Profiles of NO, O2
N2 and
Peroxynitrite Under The Endothelial Oxidative Stress
Conditions (Case 2)
Under the endothelial oxidative stress condition (Case 2), the
NO, O2
N2 and peroxynitrite concentrations are shown in
Figure 5A, C and E, respectively for the entire vessel and in
Figure 5B, D and F, respectively for a segment of the vessel
between 200 and 300 mm. Compared to the Case 1, the maximum
concentration of NO decreased at all regions of the blood vessel
and in the leukocytes. The concentration range of NO, O2
N2 and
peroxynitrite within the leukocytes were 812231 nM,
121022 pM, and 226 nM, respectively. In comparison to the
Case 1, the maximum NO concentration changed by 0.9 fold,
whereas the maximum O2
N2 and peroxynitrite concentrations
increased by 5 and 4 fold, respectively. In the CR, CF, E and SM
regions, the maximum NO concentration changed by 0.9 fold
while the maximum O2
N2 and peroxynitrite concentration
increased by 4 fold, respectively.
The radial concentration profiles of NO, O2
N2 and peroxynitrite
at location P1 and P2 are shown in Figure 6 A and B, respectively.
In comparison to the Case 1, the maximum endothelial NO
concentration changed by 0.9 fold whereas the maximum
endothelial O2
N2 and peroxynitrite concentration increased by 4
fold, at location P1 and P2, respectively (see Table 4).
The Combined Endothelial Oxidative Stress Conditions
and the Activation of Leukocytes (Case 3): Significant
Increase in Peroxynitrite Concentration Over a Length of
100 mm in Vicinity of a Leukocyte
For the combination of the endothelial oxidative stress condition
with the activation of leukocytes (Case 3), the NO, O2
N2 and
peroxynitrite concentration distribution are shown in Figure 7.
Compared to the Case 2, the maximum NO concentration
decreased at all regions of the blood vessel excluding PT region
(remained unchanged in PT region) and the leukocytes. The
concentration range of NO, O2
N2 and peroxynitrite within the
leukocytes were 782216 nM, 7000214000 pM and 23253 nM,
respectively. In comparison to the Case 2, the maximum NO
concentration changed by 0.9 fold, whereas the maximum O2
N2
and peroxynitrite concentrations increased by 14 and 8 fold,
respectively. In comparison to the Case 2, the maximum NO
concentration changed by 0.9 fold, the maximum O2
N2 concen-
tration increased by 267, 5, 3 and 2 fold, and the maximum
peroxynitrite concentration increased by 9, 7, 7 and 6 fold in the
CR, CF, E and SM regions, respectively.
Table 5. Concentration range of NO, O2
N2 and peroxynitrite
at different regions of the arteriole geometry.
Case Number Regions CNO (nM) CPer (nM) CO2
N2 (pM)
Case 1 CR 0–140 0–1 0–7
CF 3–251 0.1–2 3–310
E 6–262 1–2 251–500
IS 69–264 1–2 247–500
SM 134–292 0.4–2 0.4–290
NPT 210–389 0.1–1 0–6
PT 375–469 0.4–1 7–10
Case 2 CR 0–130 0–4 0–28
CF 0.2–230 0.4–6 14–1270
E 2–241 1–6 1040–2040
IS 65–242 1–6 1020–2030
SM 86–266 1–6 2–1240
NPT 192–353 1–3 0–26
PT 340–423 1–3 30–45
Case 3 CR 0–119 0–33 0–7470
CF 3–219 0–44 16–6430
E 4–229 1–44 1090–6830
IS 64–232 1–41 1044–5063
SM 88–260 2–37 2–2800
NPT 191–351 1–12 0–26
PT 340–423 1–3 29–45
Case 4 CR 0–162 0–8 0–990
CF 2–274 0–9 0–1100
E 0.4–286 0.1–9 220–1100
IS 61–287 0.2–8 210–1000
SM 95–305 0.3–7 0–250
NPT 209–393 0.1–2 0–5
PT 375–469 0.4–1 7–10
Case 5 CR 0–80 0–43 0–8200
CF 0.2–145 0.2–53 20–12600
E 0–152 0–53 6200–13600
IS 45–152 4–51 6100–13600
SM 61–164 6–48 20–8000
NPT 121–201 2–18 0–170
PT 206–241 6–10 220–290
doi:10.1371/journal.pone.0038912.t005
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the endothelial oxidative stress conditions results in greater fold
increase in peroxynitrite concentration as compared to increase in
O2
N2 concentration. This is due to the iNOS related NO
production from the activated leukocytes that reacts with O2
N2
to form peroxynitrite. It also shows the ability of peroxynitrite to
diffuse greater distances compared to O2
N2 [41]. In the CR region,
the increase in O2
N2 concentration is greater than peroxynitrite
due to rapid scavenging of both NO and peroxynitrite by
hemoglobin [55,56].
At the location P1 and P2, the radial concentration profiles for
NO, O2
N2 and peroxynitrite are shown in Figure 8 for the Case 3.
The location for the maxima for O2
N2 and peroxynitrite at
location P1 shifted from the endothelium (as observed in the
previous cases (Case 1 and 2)) to the lumen at distances of 20.5 and
22.3 mm, respectively from the center of the vessel. The maximum
O2
N2 and peroxynitrite concentrations were 13300 pM and
51 nM, respectively. In comparison to the Case 2, the maximum
endothelial NO concentration changed by 0.9 fold and the
maximum O2
N2 and peroxynitrite concentration increased by 3
and 6 fold, respectively at the location P1 (Table 4). However at
the location P2, the NO, O2
N2 and peroxynitrite concentrations
remained unchanged. Furthermore, the peroxynitrite increased in
the vicinity of the activated leukocytes when compared in contour
profiles of the Case 2 (Figure 5F) with the Case 3 (Figure 7F). A
Figure 3. Concentration distribution under normal physiological conditions (Case 1). Panel A, C and E shows the NO, O2
N2 and
peroxynitrite (referred as CPer) concentration distribution, respectively across the entire arteriolar geometry. Panel B, D and F shows the NO, O2
N2
and peroxynitrite concentration distribution, respectively across a segment of the arteriolar geometry between 200 and 300 mm encompassing the
luminal, E, SM and NPT regions. The endothelial and capillary based O2
N2 production rates in this case were 5% of their respective NO production
rates and the leukocytes were considered inactive.
doi:10.1371/journal.pone.0038912.g003
Figure 4. Radial concentration profiles at locations P1 and P2 for the Case 1. Panel A and B shows the radial concentration profiles of NO,
O2
N2 and peroxynitrite at the location P1 and P2, respectively.
doi:10.1371/journal.pone.0038912.g004
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peroxynitrite concentration upon activation of a single leukocyte.
SOD Effectively Reduces Oxidative Stress Associated with the
Endothelial Region and the Activation of Leukocytes (Case 4)
Experimental studies have demonstrated that the O2
N2 scavenger
superoxide dismutase (SOD) can inhibit leukocyte adhesion, reduce
adhesion molecule expression and attenuate increase in vascular
permeability [8,25]. It is thus important to understand the effect of
increased SOD on the concentration profiles from the Case 3. For
the Case 4, we increased the SOD concentration from 1 to 10 mM.
Figures 9 and 10 shows the resulting concentration distributions and
radial profiles, respectively. In comparison to the Case 3, the
maximum O2
N2 and peroxynitrite concentration reduced across all
the regions of the blood vessel and in the leukocytes.
Within the leukocytes for the Case 4, the concentration range for
NO, O2
N2 and peroxynitrite were 1062277 nM, 130021940 pM
and 5211 nM, respectively. The maximum NO concentration
increased 1.2 fold while the maximum O2
N2 and peroxynitrite
concentrations changed by 0.1 and 0.2 fold, respectively in
comparison to the Case 3. In comparison to the Case 3, the
maximum NO concentration increased by 1.4, 1.2, 1.2 and 1.1 fold
in the CR, CF, E and SM regions, respectively (see Table 5). The
maximum O2
N2 and peroxynitrite concentrations changed by
0.0820.2 fold and by 0.2 fold, respectively in the CR, CF, E and
SM regions. The peroxynitrite concentration significantly reduced
in the vicinity of the leukocyte as compared to the Case 3.
Figure 5. Concentration distribution under conditions of endothelial oxidative stress (Case 2). The NO, O2
N2 and peroxynitrite
concentration distribution are shown for the entire arteriolar geometry in Panels A, C, and E, respectively and across the 200–300 mm region in
Panels B, D and F, respectively. The endothelial and capillary based O2
N2 production rates in this case were 20% of their respective NO production
rates and the leukocytes were considered inactive.
doi:10.1371/journal.pone.0038912.g005
Figure 6. Radial concentration profiles at locations P1 and P2 for the Case 2. Panel A and B shows the radial concentration profiles of NO,
O2
N2 and peroxynitrite at the location P1 and P2, respectively.
doi:10.1371/journal.pone.0038912.g006
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endothelial NO concentration increased by 1.2 fold, respectively
in comparison to the Case 3. The O2
N2 and peroxynitrite
concentration reached their respective maximum values of
1938 pM and 10 nM at distances of 20.3 and 22.3 mm,
respectively from the center of the vessel at the location P1. The
maximum O2
N2 concentrations changed by 0.2 and 0.4 fold and
the maximum peroxynitrite concentrations changed by 0.2 fold at
the locations P1 and P2, respectively.
An Onset of Severe Oxidative Stress Condition Affects All
Regions of the Microvasculature (Case 5)
Endothelial oxidative stress in conjunction with activation of
leukocytes causes a significant increase in peroxynitrite concen-
tration in the endothelial region. An increased peroxynitrite
concentration in the endothelial region can promote the oxidation
of the eNOS co-factor BH4 to BH2 and causes eNOS uncoupling
that results in reduction of eNOS based NO production, increased
eNOS based O2
N2 production and an increase in eNOS
expression [11,57]. However, it has also been reported that under
Figure 7. Concentration distribution under combination of endothelial oxidative stress and activation of leukocytes (Case 3). The
NO, O2
N2 and peroxynitrite concentration distribution are shown for the entire arteriolar geometry in Panels A, C, and E, respectively and across the
200–300 mm region in Panels B, D and F, respectively. The O2
N2 production in the endothelium and capillary in this case were 20% of their
respective NO production and the leukocytes were in activated state producing NO and O2
N2.
doi:10.1371/journal.pone.0038912.g007
Figure 8. Radial concentration profiles at locations P1 and P2 for the Case 3. Panel A and B shows the radial concentration profiles of NO,
O2
N2 and peroxynitrite at the location P1 and P2, respectively.
doi:10.1371/journal.pone.0038912.g008
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and iNOS associated NO production from endothelial cells
[13,14]. Thus, a prolonged exposure of the endothelium to high
concentrations of peroxynitrite and leukocyte activation would
eventually increase endothelial O2
N2 production rate. In this
scenario, the endothelial O2
N2 production rate may equal or
exceed the endothelial NO production progressing the Case 3 to
the severe oxidative stress condition (Case 5).
Figures 11 and 12 show the resulting concentration distributions
and radial profiles, respectively. In comparison to the Case 3, the
NO concentration reduced at all regions of the blood vessel and
the leukocytes. Within the leukocytes for the Case 5, the
concentration range for NO, O2
N2 and peroxynitrite were
562144 nM, 6500214800 pM and 26256 nM, respectively.
The maximum NO concentration changed by 0.5 fold while the
maximum O2
N2 and peroxynitrite increased by 1.1 fold in
comparison to the Case 3. In comparison to the Case 3, the
maximum NO concentration changed by 0.6 fold and peroxyni-
trite concentrations increased by 1.3 fold across the CR, CF, E and
SM regions. The O2
N2 concentration increased by 1.123 fold in
the CR, CF, E and SM regions, respectively (See Table 5).
Furthermore at the locations P1 and P2, the maximum
endothelial NO concentration changed by 0.6 fold in comparison
to the Case 3. The O2
N2 and peroxynitrite concentration reached
their respective maximum values of 14672 pM and 55 nM at
distances of 21.0 and 23.5 mm, respectively from the center of the
vessel at the location P1. The maximum O2
N2 concentrations
increased by 2 and 6 fold and the maximum peroxynitrite
Figure 9. Concentration distribution under endothelial oxidative stress, activated leukocytes and increased SOD concentration
(Case 4). The NO, O2
N2 and peroxynitrite concentration distribution are shown for the entire arteriolar geometry in Panels A, C, and E, respectively
and across the 200–300 mm region in Panels B, D and F, respectively. The O2
N2 production in the endothelium and capillary in this case were 20%
of their respective NO production and the leukocytes were in activated state producing NO and O2
N2. The SOD concentration across all the regions of
the arteriole and within the leukocytes was set at 10 mM.
doi:10.1371/journal.pone.0038912.g009
Figure 10. Radial concentration profiles at locations P1 and P2 for the Case 4. Panel A and B shows the radial concentration profiles of NO,
O2
N2 and peroxynitrite at the location P1 and P2, respectively.
doi:10.1371/journal.pone.0038912.g010
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P2, respectively. Thus, the severe oxidative stress condition (Case5)
leads to a decrease in NO concentration across all regions of the
arteriole and a significant increase in oxidative and nitrosative
stress at regions of the arteriole previously unaffected under
conditions presented in the Case 2 and 3, respectively (regions
located between the centers of the leukocytes).
Discussion
There is a lack of sufficient measurement data of all these free
radical levels in one study to validate the findings from our study.
The modeling approach provides us improved understanding on
the quantitative aspects of the complex interactions of NO and
oxidative stress in the microcirculation. Overall, the results
predicted by our models show similar trends to experimental
observations as discussed below.
Limitations of Current Study
The model provides insight into the free radical levels changes
during endothelial–leukocyte interactions from normal to oxida-
tive stress state. The model predictions supported previous
experimental observations about the independence between
leukocyte adhesion and activation as described later. This
modeling study has certain limitations. The results may vary
depending on 1) the change in the blood vessel diameter due to
vasoregulation, 2) the change in blood flow and velocity profile in
Figure 11. Concentration distribution under severe oxidative stress conditions (Case 5). The NO, O2
N2 and peroxynitrite concentration
distribution are shown for the entire arteriolar geometry in Panels A, C, and E, respectively and across the 200–300 mm region in Panels B, D and
F, respectively. The O2
N2 production in the endothelium and capillary in this case were equal to their respective NO production and the leukocytes
were in activated state producing NO and O2
N2.
doi:10.1371/journal.pone.0038912.g011
Figure 12. Radial concentration profiles at locations P1 and P2 for the Case 5. Panel A and B shows the radial concentration profiles of NO,
O2
N2 and peroxynitrite at the location P1 and P2, respectively.
doi:10.1371/journal.pone.0038912.g012
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leukocyte migration and the presence of a nearby leukocyte.
These limitations can be addressed by solving the multi-phase
momentum transport equation involving blood and leukocytes
[58] simultaneously with the mass transport equations of the free
radical species shown in equation (1). Additionally, moving
boundary conditions need to be introduced at the interfaces
separating adjacent regions of the vascular geometry. Such
analysis will be extremely complex and will require enormous
computational resources.
Transition from Normal Physiologic Conditions (Case 1)
to Oxidative Stress Conditions (Case 2, 3 and 5) Leads to
Significant Changes in Free Radical Profiles
Upon transition from normal physiology (Case 1) to endothelial
oxidative stress conditions (Case 2), the results showed that the
maximum O2
N2 and peroxynitrite concentrations increased by 4
fold in the endothelial and smooth muscle region, respectively.
Using DHE fluorescence, Gupte et al. [59] reported a 2 fold
increase in O2
N2 levels in the diabetic aortas as compared to aortas
of healthy mice. Nagaoka et al. [60] showed that porcine arterioles
incubated with a pro-inflammatory marker CRP caused a marked
increase in O2
N2 levels in the endothelium compared to untreated
arterioles. They did not quantify the level of increase. El-Remessy
and co-workers [61] reported a 1.4 fold increase in nitrotyrosine
levels, which is an indirect indicator of peroxynitrite levels, for
diabetic rat aortas.
The NO concentration changed by 0.9 fold in the endothelial
and smooth muscle region in our simulations for the Case 2 in
comparison to the Case 1. Akamine et al. [62] estimated the NO
levels in mesenteric arterioles of normal and diabetic rats using
DAF fluorescence. They reported approximately 0.8 fold change
in NO levels of diabetic arterioles compared to normal arterioles.
On the contrary, Jebelovszki et al. [63] showed that the
endothelial dependent vasodilation in arterioles of lean and obese
rats were similar even though oxidative stress increased in vessels
of obese rats. The NO concentration range for endothelial
oxidative stress condition in the smooth muscle region predicted
by this study was 862266 nM. This is within NO levels required
for half maximal activation of sGC (232100 nM) [35].
In addition, the results from this study predicted that in
comparison to normal physiology (Case 1), the combination of
endothelial oxidative stress and leukocyte activation (Case 3)
changed the maximum NO concentration in the E and SM
regions by 0.8 fold whereas the maximum O2
N2 and peroxynitrite
concentrations increased by 10226 fold. The maximum O2
N2 and
peroxynitrite concentration in the cell-rich region increased by
1067 and 33 fold, respectively compared to normal physiology.
Zhang et al. [64] compared the levels of O2
N2 between normal and
TNF-a treated porcine coronary arterioles using DHE fluores-
cence and observed augmented levels of O2
N2 in the endothelial
and smooth muscle region. Suematsu et al. [65] showed that an
infusion of rat venules with NOS inhibitor L-NAME and
leukocyte activation agent fMLP (formyl-Met-Leu-Phe-OH)
caused a 9 fold increase in endothelium ROS concentration. In
a study involving rat microvasculature, it was observed that
treatment with PAF antagonist reduced the ROS levels in the
microvasculature by a factor of 0.6 [66].
Some of the above observations may lack the sufficient
measurement data from the system that leads to disagreement in
the modeling predictions and experimental observations. Possible
explanation for the discrepancy in the extent of changes of free
radical levels include higher O2
N2 production and lower NO
production in experimental conditions compared to the NO and
O2
N2 production rates used in our model. This could be due to
activation of several sources of O2
N2 production, inhibition or
activation of NO production sources and differences in morphol-
ogy of the endothelial cells. Additionally, oxidation of DHE by
oxidizing agents other than O2
N2 [67,68], measurement of change
in total ROS as opposed to just change in O2
N2 and inhibition of
DAF oxidation by antioxidants such as glutathione (GSH) and
ascorbate [68] can also contribute to the disagreement between
modeling and experimental results.
Consequences of Increased Oxidative Stress
Simulation of the severe oxidative stress condition (Case 5) using
the computational model in this study predicted a significant
decrease in the NO concentration and a significant increase in
O2
N2 and peroxynitrite concentration in the entire endothelial and
smooth muscle region from the levels observed in the Case 3. This
was more prominent between the leukocytes in the E and SM
regions for severe oxidative stress, whereas the O2
N2 and
peroxynitrite concentration for Case 2 and 3 were similar (refer
Table 4). A comparison between severe oxidative stress condition
(Case 5) and normal physiologic condition (Case 1) indicated that
the maximum concentrations of NO changed by 0.6 fold, O2
N2
increased by 27 and 28 fold, and peroxynitrite increased by 31 and
30 fold in the E and SM region, respectively. An increase in O2
N2
and peroxynitrite concentration and a decrease in NO concen-
tration in the vasculature has been implicated for vascular
complications resulting from leukocyte-endothelial cell interactions
[3,7,23,69].
The reduction in NO concentration in the SM region can
severely impair vasodilation. Abu Nabah et al. [70] reported that
arterioles of rats injected with eNOS inhibitor L-NAME showed a
reduction in shear rate by a factor of 0.5, possibly due to reduced
vasodilation. The increase in peroxynitrite concentration in the
SM region can cause inhibition of smooth muscle cell growth and
leads to their apoptosis. Huang et al. [71] reported that a 5 fold
increase in peroxynitrite concentration in smooth muscle cells
causes their numbers to reduce by a factor of 0.16. Increase of
O2
N2 concentration in the endothelium could lead to deregulation
of vascular permeability. Casillan et al. [66] observed a 10 fold
increase in vascular permeability when the ROS concentration in
the endothelium increased 1.6 fold. Therefore severe oxidative
stress conditions may cause impairment of vasodilation, deregu-
lation of vascular permeability, leukocyte transmigration to the
SM region and apoptosis of smooth muscle cells. These could
eventually lead to complications such as tissue edema and multiple
organ failure [5,53].
Possible Effect on Leukocytes Because of the Transition
from Normal Physiological Condition to the Endothelial
Oxidative Stress Condition
The maximum peroxynitrite concentration within the leuko-
cytes and in the CR regions increased approximately by 4 fold
upon transition from normal physiological condition (Case 1) to
the endothelial oxidative stress condition (Case 2). Rohn et al. [19]
reported that peroxynitrite is one of the priming agents for
leukocytes. An increase in peroxynitrite concentration within
leukocytes can prime them by upregulation of secondary stimulus
receptors on their surface, depolarization of their mitochondrial
membrane, increase in actin polymerization, enhancement of
NADPH oxidase activity and increase in their intracellular [Ca
2+]
concentration [19,72,73]. Additionally, the maximum O2
N2
concentration within the leukocytes and the CR regions increased
by 5 and 4 fold, respectively upon transition from the Case 1 to 2.
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N2 in the lumen through its
dismutation product H2O2 can serve as secondary stimuli to the
already primed circulating leukocytes within the lumen and
activate them to produce NO and O2
N2 without any direct
interaction with the endothelium [6,7]. Thus, priming and
activation can also occur for leukocytes circulating in the lumen
in oxidative stress conditions. This is in agreement with earlier
studies that have shown that leukocyte adhesion to the endothe-
lium and activation of leukocytes are two completely independent
events [25,74]. Additionally, the increase in peroxynitrite concen-
tration within the leukocytes and the vasculature can cause
tyrosine nitration, nitrosylation of various proteins, DNA strand
breakage, increase in gene expression such as TNF-a, IL-6, IL-1b,
ICAM-1 and P-selectin, and changes in signaling pathways such as
MAP kinase, protein kinase C and NF-kb, inactivation of anti-
oxidant SOD, cell necrosis and cell apoptosis [4,69,75].
Comparison of the simulation results in this study between
normal physiological condition (Case 1) with that of the
combination of endothelial oxidative stress and leukocyte activa-
tion (Case 3) shows that the maximum NO concentration in the
leukocytes reduced by a factor of 0.9 while the maximum O2
N2
and peroxynitrite concentration increased by 70 and 31 fold,
respectively. Chemiluminescence analysis by Zhu et al. [25] on
fMLP stimulated neutrophils indicated a 6 fold increase in their
ROS concentration. Gagnon et al. [76] used DHR 123
(dihydrorhodamine 123) based fluorescence analysis and reported
a 2.4 fold increase in peroxynitrite concentration in LPS
(lipopolysaccharide) treated granulocytes as compared to normal
granulocytes. Information regarding measurement of changes in
leukocyte NO concentration during activation of leukocytes is
insufficient. However, it is reported that inhibition of leukocyte
based NO production increases the expression of adhesion
molecules on the leukocyte surface and promotes adhesion of
leukocytes to the vessel wall [77].
If the circulating leukocytes are monocytes then the increased
O2
N2 and peroxynitrite concentration within the monocytes may
cause them to transform to macrophages [78,79]. Macrophages
can transmigrate into the SM region causing proliferation of
smooth muscle cells, ROS production from SM region, tissue
injury and eventual vascular remodeling [23,53]. The excess
peroxynitrite within the leukocytes can contribute to tissue injury
by protein tyrosine nitration [80]. However, certain studies have
argued against the role of peroxynitrite in tyrosine nitration of
proteins and have attributed it to nitrite formed from oxidation of
NO [81,82]. Our study suggests the role of peroxynitrite in
tyrosine nitration as it takes into account both the oxidation
reaction of NO and the reaction between NO and O2
N2 to form
peroxynitrite.
Importance of SOD in Reduction of O2
N2 and
Peroxynitrite Concentrations During Endothelial
Oxidative Stress Coupled with Leukocyte Activation
Several studies have shown SOD to be an effective therapeutic
agent for treatment of leukocyte-endothelial cell interaction based
vascular complications [83,84,85]. Additionally an increase in
SOD expression and activity was reported during endothelial
dysfunction [85,86]. We wanted to test the effectiveness of SOD as
a therapeutic through our model. We observed a significant
decrease in the O2
N2 and peroxynitrite levels and an increase in
the NO levels in the different regions of the vasculature and the
leukocytes upon increasing the concentration of SOD from 1 to
10 mM across all the regions of the vessel and within the leukocytes
under conditions of combined endothelial oxidative stress and
leukocyte activation (transition from the Case 3 to the Case 4). Zhu
et al. [25] compared the ROS production using chemilumines-
cence between untreated and SOD incubated neutrophils with
both subjected to fMLP stimulation and observed that ROS levels
in the SOD incubated neutrophils reduced by a factor of 0.3.
Zhu et al. [25] also reported that perfusion of venules with
fMLP stimulated neutrophils caused an increase in intracellular
Ca
2+ concentration in endothelial cells, which was reduced by a
factor of 0.7 upon perfusion with SOD. Bertuglia and Giusti [27]
showed that microvessels subjected to ischemia reperfusion had 2
fold increase in ROS production and a decrease in RBC flow
velocity by a factor of 0.9. However, ROS production and RBC
flow velocity did not increase when these microvessels were treated
with SOD. Murohara et al. [33] reported a significant reduction in
vasoconstriction and leukocyte adhesion to the endothelium in
arteries subjected to oxidative stress upon treatment of superoxide
dismutase (SOD) and nitric oxide synthase (NOS) inhibitors.
However, H2O2 and hydroxyl radial scavengers catalase and N-2-
mercaptopropionyl-glycine (MPG), respectively had minimal effect
on vasoconstriction and leukocyte adhesion.
Another qualitative study involving DHE-fluorescence imaging
of TNF-a incubated arterioles showed a significant increase in
O2
N2 concentration in the E and SM region, which was
considerably reduced upon addition of SOD mimetic Tempol
[64]. In the lumen, the maximum O2
N2 and peroxynitrite
concentrations reduced by a factor of 0.1 and 0.2, respectively
while the NO concentration increased by 1.2 fold. This could
prevent the possible priming and activation of leukocytes
circulating in the lumen and also prevent their recruitment
towards the endothelium [6,7,77]. Thus, the scavenging of O2
N2
by SOD plays a key role in reducing peroxynitrite concentration,
increasing NO bioavailability in SM region for vasodilation and
prevention of leukocyte rolling, adhesion and activation
[8,25,87,88]. SOD seems to be a promising candidate as potential
therapeutic for treatment of vascular complications arising as a
result of leukocyte-endothelial cell interactions.
In conclusion, the model developed in this study predicts the
effects of the presence of leukocytes along the endothelium on NO,
O2
N2 and peroxynitrite concentration distribution in the micro-
circulation under several endothelial oxidative stress states. The
results indicate that the onset of endothelial oxidative stress causes
an increase in both O2
N2 and peroxynitrite concentration within
the leukocytes and the lumen, which can help prime (through
peroxynitrite) and activate (secondary stimuli through O2
N2) the
leukocytes along the endothelium and those circulating in the
lumen. The results thus provide an explanation to the previous
experimental findings that leukocyte rolling/adhesion and activa-
tion are completely independent events and also explains the
limited success of anti-adhesion therapies used to prevent vascular
dysfunction [7]. The results show that the oxidative and nitrosative
stress during the leukocyte-endothelial cell interactions may
possibly contribute to microvascular dysfunction and tissue injury.
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